Pitasor 2 Dosage & Drug Information

Concise Prescribing Info

Contents

Pitavastatin

Indications/Uses

Hyperlipidaemias, mixed dyslipidaemia.

Dosage/Direction for Use

Adult Hyperlipidaemia & mixed dyslipidaemia 1-4 mg once daily. In combination w/ erythromycin & rifampicin: Max: 1- or 2 mg, respectively.

Administration

May be taken with or without food.

Contraindications

Active liver disease including unexplained, persistent elevations in serum aminotransferase (transaminase) conc. Concomitant use w/ ciclosporin. Pregnancy & lactation.

Special Precautions

Patients w/ predisposing factors for myopathy; alcoholism. Renal impairment.

Adverse Reactions

Liver enzyme abnormalities, myalgia, muscle spasm, back pain, diarrhoea, constipation, pain in extremities, arthralgia, headache, dizziness, flu, nasopharyngitis, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, malaise, fatigue, hepatitis, jaundice, hypoaesthesia, insomnia, depression, ILD, erectile dysfunction, cognitive impairment (eg, memory loss & impairment, confusion, forgetfulness, amnesia). Myopathy & rhabdomyolysis w/ acute renal failure secondary to myoglobinuria; hepatic failure.

View ADR Monitoring Form

Drug Interactions

Increased bioavailability w/ erythromycin & rifampicin. Increased risk of myopathy/rhabdomyolysis w/ gemfibrozil, colchicine, niacin & other fibrates. Significant increase in exposure w/ ciclosporin.

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA08 - pitavastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

Thai FDA Category

Presentation/Packing

Form

Pitasor 2 tab 2 mg

Packing/Price

10 × 10's

Pitasor 2

pitavastatin

Manufacturer:

Unison

Distributor:

Medline

Marketer:

Medline